№ lp_2_3_27207
File format: docx Character count: 8825 File size: 152 KB
American ginseng is a plant native to North America, known for its traditional uses in indigenous cultures and its current demand as an herbal remedy for various health issues.
Year: 2000
Region / City: United States, Canada
Topic: Ethnobotany, Plant cultivation, Herbal remedies
Document Type: Fact sheet
Organization / Institution: USDA NRCS National Plant Data Center
Author: USDA NRCS
Target Audience: General public, herbalists, researchers
Period of Validity: N/A
Approval Date: N/A
Date of Changes: N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Recruitment and Retention Plan for a 12-Week Double-Blind Placebo-Controlled Clinical Trial of American Ginseng in Patients with Ulcerative Colitis
Study duration: 12 weeks
Location: South Carolina, United States
Clinical site: Prisma Health IBD Clinic
Participating institution: University of South Carolina
Medical specialty: Gastroenterology
Disease focus: Ulcerative colitis
Intervention: American Ginseng
Study design: Double-blind placebo-controlled clinical trial
Planned sample size: 80 participants
Lead clinical collaborator: Dr. Joseph Meserve
Participant population: Adults aged 18 years and older with confirmed ulcerative colitis on stable 5-ASA therapy
Primary recruitment source: Prisma Health Gastroenterology and Hepatology patient database
Recruitment coordination: USC research team and Prisma Health staff
Inclusion criteria: Confirmed ulcerative colitis diagnosis, UCDAI score greater than 3, stable 5-ASA therapy, informed consent
Exclusion criteria: Crohn’s disease or other IBD conditions, biologic or small molecule immunotherapy use, pregnancy or breastfeeding, active infection, active malignancy, investigational drug participation, ginseng allergy, medications causing interaction risks
Participant compensation: Up to $200 via Visa gift cards
Data collection: Blood, stool, and urine samples
Recruitment methods: Patient database identification, physician referrals, brochures and flyers, clinic outreach, online announcements
Retention measures: Participant education, regular communication, flexible scheduling, incentives, community engagement
Topics: Panax quinquefolius Ginseng